JCI insight · 2018
NaV1.1 inhibition can reduce visceral hypersensitivity.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПоддержка правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Salvatierra Juan, Castro Joel, Erickson Andelain, Li Qian, Braz Joao, Gilchrist John, Grundy Luke, Rychkov Grigori Y, Deiteren Annemie, Rais Rana, King Glenn F, Slusher Barbara S, Basbaum Allan, Pasricha Pankaj J, Brierley Stuart M, Bosmans Frank
Аннотация
Functional bowel disorder patients can suffer from chronic abdominal pain, likely due to visceral hypersensitivity to mechanical stimuli. As there is only a limited understanding of the basis of chronic visceral hypersensitivity (CVH), drug-based management strategies are ill defined, vary considerably, and include NSAIDs, opioids, and even anticonvulsants. We previously reported that the 1.1 subtype of the voltage-gated sodium (NaV; NaV1.1) channel family regulates the excitability of sensory nerve fibers that transmit a mechanical pain message to the spinal cord. Herein, we investigated whether this channel subtype also underlies the abdominal pain that occurs with CVH. We demonstrate that NaV1.1 is functionally upregulated under CVH conditions and that inhibiting channel function reduces mechanical pain in 3 mechanistically distinct mouse models of chronic pain. In particular, we use a small molecule to show that selective NaV1.1 inhibition (a) decreases sodium currents in colon-innervating dorsal root ganglion neurons, (b) reduces colonic nociceptor mechanical responses, and (c) normalizes the enhanced visceromotor response to distension observed in 2 mouse models of irritable bowel syndrome. These results provide support for a relationship between NaV1.1 and chronic abdominal pain associated with functional bowel disorders.
Предметные рубрики MeSH
AnimalsChronic PainColonDisease Models, AnimalDose-Response Relationship, DrugDrug Evaluation, PreclinicalDrug StabilityGanglia, SpinalHumansIrritable Bowel SyndromeMaleMaximum Tolerated DoseMiceNAV1.1 Voltage-Gated Sodium ChannelNociceptorsPain MeasurementTrinitrobenzenesulfonic AcidVisceral PainVoltage-Gated Sodium Channel Blockers